By LANNIS HALL, ARNOLD D. BULLOCK, ANGELA L. BROWN and GRAHAM COLDITZJULY 27, 2016 [ultimate_spacer height=”32″]Full Article [ultimate_spacer height=”32″] St. Louis — In 1966, the Rev. Dr. Martin Luther King Jr. said, “Of all the forms of inequality, injustice in health care is the most shocking and inhuman.” While major advances have been made in…
July 10, 2016 Bryant Furlow [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] New biomarkers might revolutionize prostate cancer treatment, according to an educational presentation at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.1“We are now entering an era of personalized prostate cancer therapy informed by treatment-specific biomarkers, some of which can be performed using a…
Natasha Persaud, Digital Content Editor July 14, 2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Swedish researchers have provided new estimates of the hereditary risk of significant prostate cancers (PCa) that may aid in patient counseling. Clinicians have long known that having a father or brother with PCa doubles a man’s risk for the disease, but many of these cancers…
14-Jul-2016 8:05 AM [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Newswise — BUFFALO, N.Y. — While active surveillance is often recommended for patients with nonaggressive prostate cancer to reduce unnecessary treatment, the challenge for clinicians is to monitor and distinguish early-stage tumors from advanced cancers. A team of scientists led by researchers from Roswell Park Cancer Institute have…
Date:July 7, 2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Genetic testing in men with advanced prostate cancer could pick up a significant proportion whose disease may be caused by inherited mutations in genes involved in repairing DNA damage, a major new study reveals. Testing prostate cancer patients for mutations in key DNA repair genes could identify those…
Laurie McGinley July 6 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Leading American and British cancer researchers are urging that all men with advanced prostate cancer strongly consider being tested for inherited gene mutations — both to help steer their treatment and to alert family members who themselves might be at increased risk for a range of cancers. This…
By GINA KOLATA May 24, 2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Seemingly overnight, treatment of men with early-stage prostate cancer has undergone a sea change. Five years ago, nearly all opted for surgery or radiation; now, nearly half are choosing no treatment at all. The approach is called active surveillance. It means their cancers are left alone but…
Hispanic men urged to get prostate exams By Aneri Pattani GLOBE CORRESPONDENT SEPTEMBER 21, 2015 Local doctors and advocates spoke with about 1,000 parishioners Sunday at the Congregación León de Judá in the South End about the high risk of death from prostate cancer for Hispanic men in Boston. The event, which was organized by AdMeTech, a…
LAWMAKERS TEAM UP TO PUSH PROSTATE CANCER AWARENESS By Gintautas Dumcius STATE HOUSE NEWS SERVICE STATE HOUSE, BOSTON, APRIL 15, 2015…..The House and Senate may be at odds over rules that cover the flow of legislation, but lawmakers from both branches are in agreement for more awareness of early detection of prostate cancer. Joined…
Legislators, Medical Experts, Advocates Launch Statewide Prostate Cancer Education and Awareness Program MA, March 12, 2015—AdMeTech Foundation today announced the launch of a statewide prostate cancer education and awareness campaign supported by the Massachusetts Department of Public Health. The program, the first of its type statewide, also has the support of legislative leaders and advocacy groups, including…